Package 63323-690-44

{"route": ["ORAL", "RESPIRATORY (INHALATION)"], "spl_id": "eeea4928-a68a-4552-836f-d819de9de1d4", "openfda": {"nui": ["N0000175429", "N0000175961", "N0000008867", "N0000175960", "N0000175776", "N0000175547"], "unii": ["WYQ7N0BPYC"], "rxcui": ["307719"], "spl_set_id": ["8d81039e-20ef-5144-e053-2a95a90a89fd"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]"], "pharm_class_epc": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Mucolytic [EPC]"], "pharm_class_moa": ["Reduction Activity [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 VIAL in 1 CARTON (63323-690-44)  / 30 mL in 1 VIAL (63323-690-41)", "package_ndc": "63323-690-44", "marketing_start_date": "20120901"}], "brand_name": "Acetylcysteine", "product_id": "63323-690_eeea4928-a68a-4552-836f-d819de9de1d4", "dosage_form": "SOLUTION", "pharm_class": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]", "Mucolytic [EPC]", "Reduction Activity [MoA]"], "product_ndc": "63323-690", "generic_name": "ACETYLCYSTEINE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetylcysteine", "active_ingredients": [{"name": "ACETYLCYSTEINE", "strength": "200 mg/mL"}], "application_number": "ANDA203853", "marketing_category": "ANDA", "marketing_start_date": "20120901", "listing_expiration_date": "20261231"}